Global Incretin-Based Drugs Market Insights and Forecast to 2028

Global Incretin-Based Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Incretin-Based Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Incretin-Based Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Market by Application
1.3.1 Global Incretin-Based Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Incretin-Based Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Incretin-Based Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Incretin-Based Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Incretin-Based Drugs Sales by Region
2.4.1 Global Incretin-Based Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Incretin-Based Drugs by Region (2023-2028)
2.5 Global Incretin-Based Drugs Revenue by Region
2.5.1 Global Incretin-Based Drugs Revenue by Region (2017-2022)
2.5.2 Global Incretin-Based Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Incretin-Based Drugs Sales by Manufacturers
3.1.1 Global Top Incretin-Based Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Incretin-Based Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Incretin-Based Drugs in 2021
3.2 Global Incretin-Based Drugs Revenue by Manufacturers
3.2.1 Global Incretin-Based Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Incretin-Based Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Incretin-Based Drugs Revenue in 2021
3.3 Global Incretin-Based Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Incretin-Based Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Incretin-Based Drugs Sales by Type
4.1.1 Global Incretin-Based Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Incretin-Based Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Incretin-Based Drugs Sales Market Share by Type (2017-2028)
4.2 Global Incretin-Based Drugs Revenue by Type
4.2.1 Global Incretin-Based Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Incretin-Based Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Incretin-Based Drugs Price by Type
4.3.1 Global Incretin-Based Drugs Price by Type (2017-2022)
4.3.2 Global Incretin-Based Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Incretin-Based Drugs Sales by Application
5.1.1 Global Incretin-Based Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Incretin-Based Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Incretin-Based Drugs Sales Market Share by Application (2017-2028)
5.2 Global Incretin-Based Drugs Revenue by Application
5.2.1 Global Incretin-Based Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Incretin-Based Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Incretin-Based Drugs Price by Application
5.3.1 Global Incretin-Based Drugs Price by Application (2017-2022)
5.3.2 Global Incretin-Based Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Incretin-Based Drugs Market Size by Type
6.1.1 North America Incretin-Based Drugs Sales by Type (2017-2028)
6.1.2 North America Incretin-Based Drugs Revenue by Type (2017-2028)
6.2 North America Incretin-Based Drugs Market Size by Application
6.2.1 North America Incretin-Based Drugs Sales by Application (2017-2028)
6.2.2 North America Incretin-Based Drugs Revenue by Application (2017-2028)
6.3 North America Incretin-Based Drugs Market Size by Country
6.3.1 North America Incretin-Based Drugs Sales by Country (2017-2028)
6.3.2 North America Incretin-Based Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Incretin-Based Drugs Market Size by Type
7.1.1 Europe Incretin-Based Drugs Sales by Type (2017-2028)
7.1.2 Europe Incretin-Based Drugs Revenue by Type (2017-2028)
7.2 Europe Incretin-Based Drugs Market Size by Application
7.2.1 Europe Incretin-Based Drugs Sales by Application (2017-2028)
7.2.2 Europe Incretin-Based Drugs Revenue by Application (2017-2028)
7.3 Europe Incretin-Based Drugs Market Size by Country
7.3.1 Europe Incretin-Based Drugs Sales by Country (2017-2028)
7.3.2 Europe Incretin-Based Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Incretin-Based Drugs Market Size by Type
8.1.1 Asia Pacific Incretin-Based Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Incretin-Based Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Incretin-Based Drugs Market Size by Application
8.2.1 Asia Pacific Incretin-Based Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Incretin-Based Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Incretin-Based Drugs Market Size by Region
8.3.1 Asia Pacific Incretin-Based Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Incretin-Based Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Incretin-Based Drugs Market Size by Type
9.1.1 Latin America Incretin-Based Drugs Sales by Type (2017-2028)
9.1.2 Latin America Incretin-Based Drugs Revenue by Type (2017-2028)
9.2 Latin America Incretin-Based Drugs Market Size by Application
9.2.1 Latin America Incretin-Based Drugs Sales by Application (2017-2028)
9.2.2 Latin America Incretin-Based Drugs Revenue by Application (2017-2028)
9.3 Latin America Incretin-Based Drugs Market Size by Country
9.3.1 Latin America Incretin-Based Drugs Sales by Country (2017-2028)
9.3.2 Latin America Incretin-Based Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Incretin-Based Drugs Market Size by Type
10.1.1 Middle East and Africa Incretin-Based Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Incretin-Based Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Incretin-Based Drugs Market Size by Application
10.2.1 Middle East and Africa Incretin-Based Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Incretin-Based Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Incretin-Based Drugs Market Size by Country
10.3.1 Middle East and Africa Incretin-Based Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Incretin-Based Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck & Co
11.3.1 Merck & Co Corporation Information
11.3.2 Merck & Co Overview
11.3.3 Merck & Co Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Co Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AstraZeneca Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Overview
11.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eli Lilly and Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly and Company Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Corporation Information
11.7.2 Boehringer Ingelheim Overview
11.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Boehringer Ingelheim Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Takeda Pharmaceutical Company
11.8.1 Takeda Pharmaceutical Company Corporation Information
11.8.2 Takeda Pharmaceutical Company Overview
11.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Takeda Pharmaceutical Company Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Incretin-Based Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Incretin-Based Drugs Industry Chain Analysis
12.2 Incretin-Based Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Incretin-Based Drugs Production Mode & Process
12.4 Incretin-Based Drugs Sales and Marketing
12.4.1 Incretin-Based Drugs Sales Channels
12.4.2 Incretin-Based Drugs Distributors
12.5 Incretin-Based Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Incretin-Based Drugs Industry Trends
13.2 Incretin-Based Drugs Market Drivers
13.3 Incretin-Based Drugs Market Challenges
13.4 Incretin-Based Drugs Market Restraints
14 Key Findings in The Global Incretin-Based Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Incretin-Based Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Glucagon-like peptide-1 receptor (GLP-1) agonists
Table 3. Major Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Table 4. Global Incretin-Based Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Incretin-Based Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Incretin-Based Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Incretin-Based Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Incretin-Based Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Incretin-Based Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Incretin-Based Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Incretin-Based Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Incretin-Based Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Incretin-Based Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Incretin-Based Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Incretin-Based Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Incretin-Based Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Incretin-Based Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Incretin-Based Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Incretin-Based Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Incretin-Based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Incretin-Based Drugs as of 2021)
Table 21. Incretin-Based Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Incretin-Based Drugs Product Offered
Table 23. Date of Manufacturers Enter into Incretin-Based Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Incretin-Based Drugs Sales Share by Type (2017-2022)
Table 28. Global Incretin-Based Drugs Sales Share by Type (2023-2028)
Table 29. Global Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Incretin-Based Drugs Revenue Share by Type (2017-2022)
Table 32. Global Incretin-Based Drugs Revenue Share by Type (2023-2028)
Table 33. Incretin-Based Drugs Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Incretin-Based Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Incretin-Based Drugs Sales Share by Application (2017-2022)
Table 38. Global Incretin-Based Drugs Sales Share by Application (2023-2028)
Table 39. Global Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Incretin-Based Drugs Revenue Share by Application (2017-2022)
Table 42. Global Incretin-Based Drugs Revenue Share by Application (2023-2028)
Table 43. Incretin-Based Drugs Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Incretin-Based Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Incretin-Based Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Incretin-Based Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Incretin-Based Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Incretin-Based Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Incretin-Based Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Incretin-Based Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Incretin-Based Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Incretin-Based Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Incretin-Based Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Incretin-Based Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Incretin-Based Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Incretin-Based Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Incretin-Based Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Incretin-Based Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Incretin-Based Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Incretin-Based Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Major Businesses
Table 107. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. GlaxoSmithKline Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GlaxoSmithKline Recent Developments
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Major Businesses
Table 112. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Johnson & Johnson Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Johnson & Johnson Recent Developments
Table 115. Merck & Co Corporation Information
Table 116. Merck & Co Description and Major Businesses
Table 117. Merck & Co Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Merck & Co Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck & Co Recent Developments
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Major Businesses
Table 122. AstraZeneca Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. AstraZeneca Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. AstraZeneca Recent Developments
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Novartis Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Eli Lilly and Company Corporation Information
Table 131. Eli Lilly and Company Description and Major Businesses
Table 132. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Eli Lilly and Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Eli Lilly and Company Recent Developments
Table 135. Boehringer Ingelheim Corporation Information
Table 136. Boehringer Ingelheim Description and Major Businesses
Table 137. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Boehringer Ingelheim Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Boehringer Ingelheim Recent Developments
Table 140. Takeda Pharmaceutical Company Corporation Information
Table 141. Takeda Pharmaceutical Company Description and Major Businesses
Table 142. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Takeda Pharmaceutical Company Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Takeda Pharmaceutical Company Recent Developments
Table 145. Sanofi Corporation Information
Table 146. Sanofi Description and Major Businesses
Table 147. Sanofi Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Sanofi Incretin-Based Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Sanofi Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Incretin-Based Drugs Distributors List
Table 153. Incretin-Based Drugs Customers List
Table 154. Incretin-Based Drugs Market Trends
Table 155. Incretin-Based Drugs Market Drivers
Table 156. Incretin-Based Drugs Market Challenges
Table 157. Incretin-Based Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Incretin-Based Drugs Product Picture
Figure 3. Global Incretin-Based Drugs Market Share by Type in 2021 & 2028
Figure 3. Glucagon-like peptide-1 receptor (GLP-1) agonists Product Picture
Figure 4. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Product Picture
Figure 5. Global Incretin-Based Drugs Market Share by Application in 2021 & 2028
Figure 6. Oral Drugs
Figure 7. Injectable Drugs
Figure 8. Incretin-Based Drugs Report Years Considered
Figure 9. Global Incretin-Based Drugs Sales 2017-2028 (K Units)
Figure 10. Global Incretin-Based Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Incretin-Based Drugs Revenue 2017-2028 (US$ Million)
Figure 12. Global Incretin-Based Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Incretin-Based Drugs Sales Market Share by Region (2017-2022)
Figure 14. Global Incretin-Based Drugs Sales Market Share by Region (2023-2028)
Figure 15. North America Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
Figure 16. North America Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Incretin-Based Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Incretin-Based Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Incretin-Based Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Incretin-Based Drugs in the World: Market Share by Incretin-Based Drugs Revenue in 2021
Figure 27. Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Incretin-Based Drugs Sales Market Share by Type (2017-2028)
Figure 29. Global Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
Figure 30. Global Incretin-Based Drugs Sales Market Share by Application (2017-2028)
Figure 31. Global Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
Figure 32. North America Incretin-Based Drugs Sales Market Share by Type (2017-2028)
Figure 33. North America Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
Figure 34. North America Incretin-Based Drugs Sales Market Share by Application (2017-2028)
Figure 35. North America Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Incretin-Based Drugs Sales Share by Country (2017-2028)
Figure 37. North America Incretin-Based Drugs Revenue Share by Country (2017-2028)
Figure 38. U.S. Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Incretin-Based Drugs Sales Market Share by Type (2017-2028)
Figure 41. Europe Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
Figure 42. Europe Incretin-Based Drugs Sales Market Share by Application (2017-2028)
Figure 43. Europe Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
Figure 44. Europe Incretin-Based Drugs Sales Share by Country (2017-2028)
Figure 45. Europe Incretin-Based Drugs Revenue Share by Country (2017-2028)
Figure 46. Germany Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. France Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Incretin-Based Drugs Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Incretin-Based Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Incretin-Based Drugs Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Incretin-Based Drugs Revenue Share by Region (2017-2028)
Figure 57. China Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. India Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Incretin-Based Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Incretin-Based Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Incretin-Based Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Incretin-Based Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Incretin-Based Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Incretin-Based

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs